phase readout
saveNCT07266090: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
ENROLLING_BY_INVITATIONupdated 2mo ago
community read0 votes
Sponsor: Viatris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: SLE - Systemic Lupus Erythematosus
view source ↗
comments(0)
5-min edit window · permanent after that